Applied UV's Airocide(R) System Installed in Judges Rooms to Protect Participants at the 28th Grand International Wine Award "MUNDUS VINI" 2021
- Installation of Fifty Airocide® Systems Highlights Growing Demand for Better Air Quality at Live Indoor Events
- Leveraging industry recognition to expand market share in rapidly growing wine industry
- Airocide® Named Official Partner of "MUNDUS VINI" 2021
MOUNT VERNON, NY / ACCESSWIRE / June 2, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that it was chosen to supply the Airocide™ System of air purification technology for the 28th Grand International Wine Award "MUNDUS VINI" 2021. Airocide® is a leader in both the US and EU wine industry for its ability to protect stored and perishable aging wines from mold and other fungi and bacteria. The opportunity to deploy Airocide® Systems at the "MUNDUS VINI" event to protect participants from harmful pathogens in the air was a natural extension of its recognized capabilities in the wine industry.
MUNDUS VINI Spring Tasting event is one of the one of the largest wine competitions, with more than 300 international, highly recognized wine experts from the trade, gastronomy, wine making, wine business and wine media attending and where more than 7,500 samples of wine are judged. The competition typically lasts a few days; however, with strict Pandemic regulations in place to protect the participants, the event stretched to 20 days. The installation of 50 Airocide® Systems at the event was a critical initiative undertaken by the event sponsors to provide a safer, cleaner environment for all the participants.
"The re-opening of the economy, especially for live-events held indoors that attract a large audience, is essential for many businesses", said Q Saeed, CEO of Applied UV. "We were very pleased to be named the official partner of this event; and most importantly, that the Airocide® air purification system provided the necessary level of safety for this prestigious wine event to take place while still under challenging Covid-related restrictions."
The Airocide® System, originally developed by NASA with assistance from the University of Wisconsin at Madison, is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst. Listed as an FDA Class II Medical device, the Airocide® technology is clinically proven and field tested to kill/remove/eliminate airborne pathogenic and non-pathogenic microorganisms, allergens, odors and harmful VOCs in a variety of applications and industries including healthcare, hospitality, grocery chains, wineries, commercial real estate, schools, dental offices and homes. Airocide® air purifiers are available at www.airocide.com.
About Applied UV
Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® products for air purification, developed by NASA and FDA Cleared as class II medical devices, utilize a proprietary photo-catalytic bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous pathogens, destructive VOCs and biological gasses into harmless water vapor without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, and homes.
The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements to conform these statements to actual results.
Applied UV Investor Relations
SOURCE: Applied UV, Inc.
View source version on accesswire.com: